Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors.

Habert R, Muczynski V, Grisin T, Moison D, Messiaen S, Frydman R, Benachi A, Delbes G, Lambrot R, Lehraiki A, N'tumba-Byn T, Guerquin MJ, Levacher C, Rouiller-Fabre V, Livera G.

Reproduction. 2014 Mar 6;147(4):R119-29. doi: 10.1530/REP-13-0497. Print 2014. Review.


A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound.

Eladak S, Grisin T, Moison D, Guerquin MJ, N'Tumba-Byn T, Pozzi-Gaudin S, Benachi A, Livera G, Rouiller-Fabre V, Habert R.

Fertil Steril. 2015 Jan;103(1):11-21. doi: 10.1016/j.fertnstert.2014.11.005. Epub 2014 Dec 2. Review.


Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal leydig cell function.

N'Tumba-Byn T, Moison D, Lacroix M, Lecureuil C, Lesage L, Prud'homme SM, Pozzi-Gaudin S, Frydman R, Benachi A, Livera G, Rouiller-Fabre V, Habert R.

PLoS One. 2012;7(12):e51579. doi: 10.1371/journal.pone.0051579. Epub 2012 Dec 17.


Effects of endocrine disruptors on the human fetal testis.

Rouiller-Fabre V, Habert R, Livera G.

Ann Endocrinol (Paris). 2014 May;75(2):54-7. doi: 10.1016/j.ando.2014.03.010. Epub 2014 Apr 29. Review.


Man is not a big rat: concerns with traditional human risk assessment of phthalates based on their anti-androgenic effects observed in the rat foetus.

Habert R, Livera G, Rouiller-Fabre V.

Basic Clin Androl. 2014 Sep 2;24:14. doi: 10.1186/2051-4190-24-14. eCollection 2014.


An investigation of the endocrine-disruptive effects of bisphenol a in human and rat fetal testes.

Ben Maamar M, Lesné L, Desdoits-Lethimonier C, Coiffec I, Lassurguère J, Lavoué V, Deceuninck Y, Antignac JP, Le Bizec B, Perdu E, Zalko D, Pineau C, Chevrier C, Dejucq-Rainsford N, Mazaud-Guittot S, Jégou B.

PLoS One. 2015 Feb 23;10(2):e0117226. doi: 10.1371/journal.pone.0117226. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128051.


Effects of mono-(2-ethylhexyl) phthalate (MEHP) on chicken germ cells cultured in vitro.

Guibert E, Prieur B, Cariou R, Courant F, Antignac JP, Pain B, Brillard JP, Froment P.

Environ Sci Pollut Res Int. 2013 May;20(5):2771-83. doi: 10.1007/s11356-013-1487-2. Epub 2013 Jan 25.


Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates.

Habert R, Muczynski V, Lehraiki A, Lambrot R, Lécureuil C, Levacher C, Coffigny H, Pairault C, Moison D, Frydman R, Rouiller-Fabre V.

Folia Histochem Cytobiol. 2009;47(5):S67-74. doi: 10.2478/v10042-009-0056-5. Review.


In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment.

Jones S, Boisvert A, Francois S, Zhang L, Culty M.

Biol Reprod. 2015 Oct;93(4):92. doi: 10.1095/biolreprod.115.129098. Epub 2015 Aug 26.


A critical assessment of the endocrine susceptibility of the human testis to phthalates from fetal life to adulthood.

Albert O, Jégou B.

Hum Reprod Update. 2014 Mar-Apr;20(2):231-49. doi: 10.1093/humupd/dmt050. Epub 2013 Sep 29. Review.


Of mice and men (and rats): phthalate-induced fetal testis endocrine disruption is species-dependent.

Johnson KJ, Heger NE, Boekelheide K.

Toxicol Sci. 2012 Oct;129(2):235-48. doi: 10.1093/toxsci/kfs206. Epub 2012 Jun 14. Review.


Human fetal testis xenografts are resistant to phthalate-induced endocrine disruption.

Heger NE, Hall SJ, Sandrof MA, McDonnell EV, Hensley JB, McDowell EN, Martin KA, Gaido KW, Johnson KJ, Boekelheide K.

Environ Health Perspect. 2012 Aug;120(8):1137-43. doi: 10.1289/ehp.1104711. Epub 2012 Apr 17.


Ontogenesis of testicular function in humans.

Rouiller-Fabre V, Muczynski V, Lambrot R, Lécureuil C, Coffigny H, Pairault C, Moison D, Angenard G, Bakalska M, Courtot AM, Frydman R, Habert R.

Folia Histochem Cytobiol. 2009;47(5):S19-24. doi: 10.2478/v10042-009-0065-4.


Time- and dose-related effects of di-(2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro.

Chauvigné F, Menuet A, Lesné L, Chagnon MC, Chevrier C, Regnier JF, Angerer J, Jégou B.

Environ Health Perspect. 2009 Apr;117(4):515-21. doi: 10.1289/ehp.11870. Epub 2008 Dec 1.


Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis.

Chauvigné F, Plummer S, Lesné L, Cravedi JP, Dejucq-Rainsford N, Fostier A, Jégou B.

PLoS One. 2011;6(11):e27172. doi: 10.1371/journal.pone.0027172. Epub 2011 Nov 7.


Species-specific dibutyl phthalate fetal testis endocrine disruption correlates with inhibition of SREBP2-dependent gene expression pathways.

Johnson KJ, McDowell EN, Viereck MP, Xia JQ.

Toxicol Sci. 2011 Apr;120(2):460-74. doi: 10.1093/toxsci/kfr020. Epub 2011 Jan 25.


Disruption of rat testis development following combined in utero exposure to the phytoestrogen genistein and antiandrogenic plasticizer di-(2-ethylhexyl) phthalate.

Jones S, Boisvert A, Duong TB, Francois S, Thrane P, Culty M.

Biol Reprod. 2014 Sep;91(3):64. doi: 10.1095/biolreprod.114.120907. Epub 2014 Jul 16.


Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro.

Dankers AC, Roelofs MJ, Piersma AH, Sweep FC, Russel FG, van den Berg M, van Duursen MB, Masereeuw R.

Toxicol Sci. 2013 Dec;136(2):382-91. doi: 10.1093/toxsci/kft198. Epub 2013 Sep 6.


A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development.

Chevalier N, Brucker-Davis F, Lahlou N, Coquillard P, Pugeat M, Pacini P, Panaïa-Ferrari P, Wagner-Mahler K, Fénichel P.

Hum Reprod. 2015 Feb;30(2):447-53. doi: 10.1093/humrep/deu340. Epub 2014 Dec 19.


Diethylstilboestrol exposure does not reduce testosterone production in human fetal testis xenografts.

Mitchell RT, Sharpe RM, Anderson RA, McKinnell C, Macpherson S, Smith LB, Wallace WH, Kelnar CJ, van den Driesche S.

PLoS One. 2013 Apr 19;8(4):e61726. doi: 10.1371/journal.pone.0061726. Print 2013.

Supplemental Content

Support Center